表紙
市場調査レポート

世界のポイントオブケア(POC)感染症検査市場の新たなフロンティア:ビジネス上の課題、新規技術、競争環境

POC/Point-of-Care Infectious Disease Testing Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape

発行 Venture Planning Group 商品コード 304988
出版日 ページ情報 英文 835 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。

Local License: 同一事業所内

Back to Top
世界のポイントオブケア(POC)感染症検査市場の新たなフロンティア:ビジネス上の課題、新規技術、競争環境 POC/Point-of-Care Infectious Disease Testing Market New Frontiers, Business Challenges, Emerging Technologies, Competitive Landscape
出版日: ページ情報: 英文 835 Pages
概要

当レポートでは、世界の主要国(米国・ドイツ・スペイン)におけるポイントオブケア(POC)向けの感染症検査関連市場の現状・将来展望について分析し、関連技術および市場(検査試薬・試薬など)の最新状況や、国別・部門別の市場規模および成長率(今後5年間分)、規制環境、競争構造、今後の需要・技術活用方法の方向性、主要企業のプロファイルなどを調査しております。

イントロダクション

エグゼクティブ・サマリー

分散型検査製品の合理的根拠

世界の技術・市場の概況

  • AIDS
  • アデノウイルス
  • カンピロバクター
  • カンジダ菌
  • クラミジア
  • クロストリジウム・ディフィシレ
  • サイトメガロウイルス
  • エンテロウイルス
  • エプスタイン・バー(EB)ウイルス
  • 淋病
  • ヘリコバクターピロリ菌
  • 肝炎
  • 単純ヘルペスウイルス
  • ヒトヘルペスウイルス6型(HHV-6)
  • インフルエンザウイルス
  • レジオネラ
  • ライム病
  • はしか(麻疹)
  • 髄膜炎
  • 単核症
  • おたふく風邪
  • マイコプラズマ
  • パピロマウイルス
  • 肺炎
  • 呼吸器合胞体ウイルス(RSV)
  • リウマチ性関節炎
  • ロタウイルス(レオウイルス)
  • 風疹
  • サルモネラ菌
  • 赤痢菌
  • 黄色ブドウ球菌
  • 連鎖球菌
  • 梅毒
  • 感染症検査用解析装置(Abbott、Beckman Coulter/Danaher、bioMeriuex、Ortho-Clinical Diagnostics、Roche、Siemens、東ソー、Wallacほか)

現在・将来の技術

  • モノクローナル抗体
  • 疫学的検定
  • ドライケミストリー
  • バイオセンサー
  • IT・自動化
  • 分子診断

米国市場

  • 市場概況
    • ビジネス環境
    • 市場構造
  • 開業医・グループ診断
  • 補助的医療施設
  • がんクリニック
  • 外来治療センター
  • 外科手術センター
  • 介護施設
  • 産院
  • 主要サプライヤーの装置配置方法、設置ベース、検査装置・消耗品の売上高・市場シェア

ドイツ市場

  • ビジネス環境
  • 市場構造
  • 市場概況
  • 検査件数・売上高予測
  • 主要サプライヤーの装置配置方法、設置ベース、検査装置・消耗品の売上高・市場シェア

スペイン市場

  • ビジネス環境
  • 市場構造
  • 市場概況
  • 検査件数・売上高予測
  • 主要サプライヤーの装置配置方法、設置ベース、検査装置・消耗品の売上高・市場シェア

製品開発の主な機会

分散型検査製品の設計基準

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 主な種類の流通業者
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 技術の限界
  • 特許保護
  • 規制による抑制
  • 分散検査市場の課題

競合企業プロファイル

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • 富士レビオ/Innogenetics
  • Grifols/Novartis Diagnostics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Lonza
  • Nanogen/Elitech
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • タカラバイオ
  • Thermo Fisher/Life Technology
  • Wallac/PE
  • 和光純薬工業

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPPOC19995

VPGMarketResearch’s new report provides comprehensive analysis of the  POC infections disease testing market, including its dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation

- Review of the POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

- Five-year test volume and reagent sales forecasts for major infectious disease tests by market segment:
Physician Offices/Group Practices Emergency Rooms Ambulatory Care Centers Surgery Centers Birth Centers

Sales and Market Share Analysis

- Sales and market shares of major reagent and instrument suppliers.

Infectious Disease Tests

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter, Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium, Cyclospora, CMV, E. Coli, Echovirus,  Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea, Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis (A, B, C, D, E), Herpes Simplex Virus, Human Herpes Virus-6 (HHV-6), Influenza, Legionella, Lyme disease, Pymphogranuloma, Malaria, Measles, Meningitis, Mononucleosis, Microsporidium, Mononucleosis, Mumps, Mycoplasma, Polyomaviruses, Parvovirus B19, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rheumatoid Arthritis, Rotavirus , Rubella, Salmonellosis, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, Tuberculois, Vibrio, West Nile, Yersenia.

Technology Review

- Emerging technologies and their applications for POC testing. Comprehensive listings of companies developing or marketing POC diagnostic technologies and products, by test.

Strategic Recommendations

- Specific opportunities for new POC instruments and reagent systems with potentially significant market appeal during the next five years. Design criteria for POC testing products. Alternative business expansion strategies. Potential market entry barriers and risks.

Competitive Assessments

- Assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

- The companies analyzed in the report include:

   - Abbott    - ADI/American Diagnostica    - Agilent Technologies    - Alere/Biosite/Inverness    - Axis-Shield    - Beckman Coulter/Danaher    - Becton Dickinson    - Bio/Data    - Biomerieux    - Bio-Rad    - Cepheid    - Chrono-Log    - Corgenix    - Decode Genetics    - Diadexus    - Diagnocure    - Diagnostica Stago/Trinity Biotech    - Diamedix/Erba    - Diasorin    - Eiken Chemical    - EKF Diagnostics    - Fujirebio    - Grifols    - Helena Laboratories    - Hologic/Gen-Probe    - Horiba    - Instrumentation Laboratory    - International Technidyne/Nexus DX    - Kreatech/Leica    - Kyowa Medex    - Lonza    - Mackay Life Sciences    - Matritech    - Nihon Kohden    - Ortho-Clinical Diagnostics    - Polartechnics    - Polymedco    - Qiagen    - Roche    - SDIX    - Sequenom    - Siemens    - Sienco    - Sysmex    - Takara Bio    - ThermoFisher    - Tosoh    - Wako    - Zycare/Alere

Methodology

This report is based on a combination of primary and secondary sources of information, including review of recent technical and business publications, manufacturer product literature, industry analyst reports, and VPGMarketResearch's proprietary data files.

Contains 835 pages and 80 tables

Table of Contents

Introduction

Executive Summary

Rationale for Testing Decentralization

  • 1. Overview
  • 2. Regulatory Trends
  • 3. Economic Trends
  • 4. Demographic Trends
  • 5. Technological Trends
  • 6. Social Trends
  • 7. Quality of Care
  • 8. Defensive Medicine
  • 9. Quality Control Issues

Worldwide Market and Technology Overview

  • 1. AIDS
  • 2. Adenovirus
  • 3. Campylobacter
  • 4. Candida
  • 5. Chlamydia
  • 6. Clostridium Difficile
  • 7. Cytomegalovirus
  • 8. Enteroviruses
  • 9. Epstein-Barr Virus
  • 10. Gonorrhea
  • 11. Helicobacter Pylori
  • 12. Hepatitis
    • a. Hepatitis A
    • b. Hepatitis B
    • c. Hepatitis C
    • d. Hepatitis D
  • 13. Herpes Simplex Virus
  • 14. Human Herpes Virus-6 (HHV-6)
  • 15. Influenza Viruses
  • 16. Legionella
  • 17. Lyme Disease
  • 18. Measles (Rubeola)
  • 19. Meningitis
  • 20. Mononucleosis
  • 21. Mumps
  • 22. Mycoplasma
  • 23. Papillomaviruses
  • 24. Pneumonia
  • 25. Respiratory Syncytial Virus (RSV)
  • 26. Rheumatoid Arthritis
  • 27. Rotavirus (Reovirus)
  • 28. Rubella (German Measles)
  • 29. Salmonellosis
  • 30. Shigellosis
  • 31. Staphylococcus Aureus
  • 32. Streptococci
  • 33. Syphilis
  • Instrumentation: Infectious Disease Analyzers Manufactured by:
  • Abbott
  • Beckman Coulter/Danaher
  • bioMeriuex
  • Ortho-Clinical Diagnostics
  • Roche
  • Siemens
  • Tosoh
  • Wallac, and other suppliers

Current and Emerging Technologies

  • 1. Monoclonal Antibodies
  • 2. Immunoassays
    • a. Technological Principle
    • b. Enzyme Immunoassays (EIA)
    • Overview
    • ELISA
    • Dot Immunobinding Assays
    • Capillary Immunoassays
    • Particle-Membrane Capture Immunoassay
    • Enzyme Amplification
  • c. Fluorescent Immunoassays
    • Fluorescent Polarization
    • Time-Resolved Pulse Fluorescence
  • d. Luminescence
    • Chemiluminescence
    • Bioluminescence
    • e. Latex Agglutination
    • f. Immunoprecipitation
  • 3. Dry Chemistry
  • 4. Biosensors
  • 5. IT and Automation
  • 6. Molecular Diagnostics
    • a. Technology Overview
    • b. Amplification Methods
      • Polymerase Chain Reaction
      • Ligase Chain Reaction
      • Branched DNA
      • Q-Beta Replicase
      • Strand Displacement Activation
      • Self-Sustained Sequence Replicase

U.S.A.

  • A. Market Overview
    • 1. Business Environment
      • a. Health Care Expenditures
      • b. Cost Consciousness
      • c. Reimbursement
      • d. Industry Consolidation
      • e. Managed Care
        • PPO
        • HMO
      • f. Hospitals
      • g. Admissions
      • h. Length of Stay
      • i. Industry Diversification
      • j. Physician Demographics
      • k. Aging Population
        • More Chronic Illness
        • Disease Incidence
        • Susceptibility to latrogenesis
        • Multiple Illnesses Cases
      • l. Laboratory Regulations
    • 2. Market Structure
      • a. Hospitals
      • b. Commercial/Private Laboratories
  • C. Physician Offices/Group Practices
    • 1. Market Summary
    • 2. Market Structure
    • 3. Test Volume and Sales Forecasts
  • D. Ancillary Hospital Locations
    • 1. Introduction
      • a. Emergency Departments
      • b. Operating Suites
      • c. Intensive Care Units
    • 2. Emergency Departments
      • a. Market Summary
      • b. Test volume and Sales Forecasts
    • 3. Operating and Recovery Suites
      • a. Market Summary
      • b. Test Volume and Sales Forecasts
    • 4. ICUs/CCUs
      • a. Market Summary
      • b. Test Volume and Sales Forecasts
  • E. Cancer Clinics
    • 1. Introduction
    • 2. Market Summary
    • 3. Test Volume and Sales Forecasts
  • F. Ambulatory Care Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • G. Surgery Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • H. Nursing Homes
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • I. Birth Centers
    • 1. Introduction
    • 2. Market Summary
    • 3. Market Structure
    • 4. Test Volume and Sales Forecasts
  • J. Major Suppliers' Instrument Placements, Installed Base, Reagent Sales and Market Shares

Germany

  • A. Market Overview
  • B. Market Structure
  • C. Market Summary
  • D. Major Suppliers' Reagent Sales and Market Shares

Spain

  • A. Business Environment
  • B. Market Structure
  • C. Market Summary
  • D. Major Suppliers' Reagent Sales and Market Shares

Major Product Development Opportunities

Design Criteria for Decentralized Testing Products

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Company Profile

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Grifols/Novartis Diagnostics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Lonza
  • Nanogen/Elitech
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher/Life Technology
  • Wallac/PE
  • Wako

List of Tables

  • Major Companies Developing or Marketing AIDS Tests
  • Major Companies Developing or Marketing Adenovirus Tests
  • Major Companies Developing or Marketing Campylobacter Tests
  • Major Companies Developing or Marketing Candida Tests
  • Major Companies Developing or Marketing CMV Tests
  • Major Companies Developing or Marketing EBV Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Helicobacter Pylori Tests
  • Major Companies Developing or Marketing Hepatitis Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Influenza Tests
  • Major Companies Developing or Marketing Legionella Tests
  • Major Companies Developing or Marketing Lyme Disease Tests
  • Major Companies Developing or Marketing Measles Tests
  • Major Companies Developing or Marketing Meningitis Tests
  • Major Companies Developing or Marketing Mononucleosis Tests
  • Major Companies Developing or Marketing Mumps Tests
  • Major Companies Developing or Marketing Mycoplasma Tests
  • Major Companies Developing or Marketing Pneumonia Tests
  • Major Companies Developing or Marketing RSV Tests
  • Major Companies Developing or Marketing Rotavirus Tests
  • Major Companies Developing or Marketing Rubella Tests
  • Major Companies Developing or Marketing Salmonella Tests
  • Major Companies Developing or Marketing Shigella Tests
  • Major Companies Developing or Marketing Streptococci Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • U.S.A., Physician Office/Group Practice Laboratories Forecast by Practice Size
  • U.S.A., Physician Offices/Group Practices Forecast by Type
  • U.S.A., Office-Based Physicians Forecast by Practice Type
  • U.S.A., Physician Offices/Group Practices Infectious Disease Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Microbiology Test Volume Forecast
  • U.S.A., Physician Offices/Group Practices Infectious Disease Reagent and Instrument Sales Forecast
  • U.S.A., Physician Offices/Group Practices Microbiology Reagent and Instrument Sales Forecast
  • U.S.A., Ancillary Hospital Locations Estimated Number
  • U.S.A., Ancillary Hospital Locations Annual Utilization
  • U.S.A., Hospital Emergency Departments Infectious Disease Test Volume Forecast
  • U.S.A., Hospital Emergency Departments Infectious Disease Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Estimated Number of Facilities and Patient Visits
  • U.S.A., Ambulatory Care Centers Most Frequent Diagnoses
  • U.S.A., Ambulatory Care Centers Infectious Disease Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Microbiology And Serology Test Volume Forecast
  • U.S.A., Ambulatory Care Centers Infectious Disease Reagent and Instrument Sales Forecast
  • U.S.A., Ambulatory Care Centers Microbiology and Serology Reagent and Instrument Sales Forecast
  • U.S.A., Surgery Centers Most Frequently Performed Procedures
  • U.S.A., Surgery Centers Microbiology and Serology Test Volume Forecast
  • U.S.A., Surgery Centers Microbiology And Serology Reagent and Instrument Sales Forecast
  • U.S.A., Birth Centers Facilities, Patient Visits, and Births
  • U.S.A., Birth Centers Microbiology and Serology Test Volume Forecast
  • U.S.A., AIDS Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Chlamydia Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., CMV Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Gonorrhea Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Helicobacter Pylori Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Hepatitis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Herpes Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Influenza Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Lyme Disease Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Rubella Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Streptococci Testing Market Estimated Market Shares of Major Suppliers
  • U.S.A., Syphilis Testing Market Estimated Market Shares of Major Suppliers
  • Germany, Laboratory Performing Diagnostic Tests by Market Segment
  • Germany, AIDS Testing Market Estimated Market Share of Major Suppliers
  • Germany, Gonorrhea Testing Market Estimated Market Share of Major Suppliers
  • Germany, Hepatitis Testing Market Estimated Market Share of Major Suppliers
  • Germany, Herpes Testing Market Estimated Market Share of Major Suppliers
  • Germany, Influenza Testing Market Estimated Market Share of Major Suppliers
  • Germany, Mononucleosis Testing Market Estimated Market Share of Major Suppliers
  • Germany, Septicemia Testing Market Estimated Market Share of Major Suppliers
  • Germany, Streptococci Testing Market Estimated Market Share of Major Suppliers
  • Spain, Laboratory Performing Infectious Disease Tests by Market Segment
  • Spain, AIDS Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Chlamydia Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Hepatitis Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Herpes Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Influenza Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Mononucleosis Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Rubella Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Streptococci Testing Market Estimated Market Shares of Major Suppliers
  • Spain, Syphilis Testing Market Estimated Market Shares of Major Suppliers
Back to Top